Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milena Bond

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
RMD Open|June 22, 2023
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task forceCatalina Sanchez-Alvarez, Milena Bond, Medha Soowamber, et al.
Vascular Medicine (London, England)|December 6, 2019
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001-2017)Francesca Valent, Milena Bond, Elena Cavallaro, et al.
Rheumatology (Oxford, England)|May 14, 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failureAlessandro Tomelleri, Milena Bond, Chiara Marvisi, et al.
Clinical and Experimental Rheumatology|May 26, 2018
One year in review 2018: systemic vasculitisElena Elefante, Milena Bond, Sara Monti, et al.
Journal of Internal Medicine|August 27, 2025
Predictors of remission and relapse in retroperitoneal fibrosisMilena Bond, Alessandra Bettiol, Eugenia Accorsi Buttini, et al.
Clinical and Experimental Rheumatology|May 3, 2020
One year in review 2020: vasculitisMara Felicetti, Elena Treppo, Chiara Posarelli, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label studyCesare Mazzaro, Luigino Dal Maso, Luca Quartuccio, et al.
RMD Open|May 29, 2025
Definitions of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working GroupAlessandro Tomelleri, Christian Dejaco, Wolfgang A Schmidt, et al.
Rheumatology (Oxford, England)|March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre studyAdrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Annals of the Rheumatic Diseases|August 7, 2023
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 updateChristian Dejaco, Sofia Ramiro, Milena Bond, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
RMD Open|June 22, 2023
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task forceCatalina Sanchez-Alvarez, Milena Bond, Medha Soowamber, et al.
Vascular Medicine (London, England)|December 6, 2019
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001-2017)Francesca Valent, Milena Bond, Elena Cavallaro, et al.
Rheumatology (Oxford, England)|May 14, 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failureAlessandro Tomelleri, Milena Bond, Chiara Marvisi, et al.
Clinical and Experimental Rheumatology|May 26, 2018
One year in review 2018: systemic vasculitisElena Elefante, Milena Bond, Sara Monti, et al.
Journal of Internal Medicine|August 27, 2025
Predictors of remission and relapse in retroperitoneal fibrosisMilena Bond, Alessandra Bettiol, Eugenia Accorsi Buttini, et al.
Clinical and Experimental Rheumatology|May 3, 2020
One year in review 2020: vasculitisMara Felicetti, Elena Treppo, Chiara Posarelli, et al.
Clinical and Experimental Rheumatology|February 22, 2018
Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label studyCesare Mazzaro, Luigino Dal Maso, Luca Quartuccio, et al.
RMD Open|May 29, 2025
Definitions of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working GroupAlessandro Tomelleri, Christian Dejaco, Wolfgang A Schmidt, et al.
Rheumatology (Oxford, England)|March 26, 2025
Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre studyAdrien Cottu, Laure Delaval, Alexandra Forestier, et al.
Annals of the Rheumatic Diseases|August 7, 2023
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 updateChristian Dejaco, Sofia Ramiro, Milena Bond, et al.
Pageof 4